Logo image of DORM

DORMAN PRODUCTS INC (DORM) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:DORM - US2582781009 - Common Stock

128.79 USD
+2.69 (+2.13%)
Last: 1/15/2026, 8:00:01 PM
128.79 USD
0 (0%)
After Hours: 1/15/2026, 8:00:01 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to DORM. DORM was compared to 42 industry peers in the Automobile Components industry. DORM has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. DORM has a decent growth rate and is not valued too expensively. With these ratings, DORM could be worth investigating further for quality investing!.


Dividend Valuation Growth Profitability Health

9

1. Profitability

1.1 Basic Checks

  • DORM had positive earnings in the past year.
  • DORM had a positive operating cash flow in the past year.
  • In the past 5 years DORM has always been profitable.
  • DORM had a positive operating cash flow in each of the past 5 years.
DORM Yearly Net Income VS EBIT VS OCF VS FCFDORM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

1.2 Ratios

  • Looking at the Return On Assets, with a value of 9.70%, DORM belongs to the top of the industry, outperforming 90.48% of the companies in the same industry.
  • DORM's Return On Equity of 16.70% is amongst the best of the industry. DORM outperforms 92.86% of its industry peers.
  • DORM's Return On Invested Capital of 13.16% is amongst the best of the industry. DORM outperforms 90.48% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for DORM is in line with the industry average of 9.10%.
  • The 3 year average ROIC (9.34%) for DORM is below the current ROIC(13.16%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 9.7%
ROE 16.7%
ROIC 13.16%
ROA(3y)6.22%
ROA(5y)7.06%
ROE(3y)12.47%
ROE(5y)12.81%
ROIC(3y)9.34%
ROIC(5y)9.92%
DORM Yearly ROA, ROE, ROICDORM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20

1.3 Margins

  • Looking at the Profit Margin, with a value of 11.65%, DORM belongs to the top of the industry, outperforming 97.62% of the companies in the same industry.
  • DORM's Profit Margin has improved in the last couple of years.
  • Looking at the Operating Margin, with a value of 16.71%, DORM belongs to the top of the industry, outperforming 97.62% of the companies in the same industry.
  • DORM's Operating Margin has improved in the last couple of years.
  • DORM has a Gross Margin of 41.88%. This is amongst the best in the industry. DORM outperforms 85.71% of its industry peers.
  • In the last couple of years the Gross Margin of DORM has grown nicely.
Industry RankSector Rank
OM 16.71%
PM (TTM) 11.65%
GM 41.88%
OM growth 3Y4.55%
OM growth 5Y6.44%
PM growth 3Y-1.1%
PM growth 5Y2.27%
GM growth 3Y5.26%
GM growth 5Y3.2%
DORM Yearly Profit, Operating, Gross MarginsDORM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30 40

7

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so DORM is still creating some value.
  • Compared to 1 year ago, DORM has less shares outstanding
  • The number of shares outstanding for DORM has been reduced compared to 5 years ago.
  • The debt/assets ratio for DORM has been reduced compared to a year ago.
DORM Yearly Shares OutstandingDORM Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
DORM Yearly Total Debt VS Total AssetsDORM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

2.2 Solvency

  • An Altman-Z score of 4.71 indicates that DORM is not in any danger for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 4.71, DORM belongs to the top of the industry, outperforming 80.95% of the companies in the same industry.
  • The Debt to FCF ratio of DORM is 4.33, which is a neutral value as it means it would take DORM, 4.33 years of fcf income to pay off all of its debts.
  • DORM has a Debt to FCF ratio of 4.33. This is in the better half of the industry: DORM outperforms 66.67% of its industry peers.
  • DORM has a Debt/Equity ratio of 0.28. This is a healthy value indicating a solid balance between debt and equity.
  • DORM has a Debt to Equity ratio of 0.28. This is in the better half of the industry: DORM outperforms 64.29% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF 4.33
Altman-Z 4.71
ROIC/WACC1.47
WACC8.95%
DORM Yearly LT Debt VS Equity VS FCFDORM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2.3 Liquidity

  • A Current Ratio of 2.94 indicates that DORM has no problem at all paying its short term obligations.
  • With a decent Current ratio value of 2.94, DORM is doing good in the industry, outperforming 78.57% of the companies in the same industry.
  • DORM has a Quick Ratio of 1.19. This is a normal value and indicates that DORM is financially healthy and should not expect problems in meeting its short term obligations.
  • DORM has a Quick ratio (1.19) which is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.94
Quick Ratio 1.19
DORM Yearly Current Assets VS Current LiabilitesDORM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

5

3. Growth

3.1 Past

  • DORM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 36.71%, which is quite impressive.
  • The Earnings Per Share has been growing by 21.83% on average over the past years. This is a very strong growth
  • Looking at the last year, DORM shows a small growth in Revenue. The Revenue has grown by 7.94% in the last year.
  • The Revenue has been growing by 15.18% on average over the past years. This is quite good.
EPS 1Y (TTM)36.71%
EPS 3Y15.37%
EPS 5Y21.83%
EPS Q2Q%33.67%
Revenue 1Y (TTM)7.94%
Revenue growth 3Y14.31%
Revenue growth 5Y15.18%
Sales Q2Q%7.93%

3.2 Future

  • DORM is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.80% yearly.
  • DORM is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.18% yearly.
EPS Next Y26.18%
EPS Next 2Y16.16%
EPS Next 3Y14.91%
EPS Next 5Y7.8%
Revenue Next Year8.33%
Revenue Next 2Y6.78%
Revenue Next 3Y6.27%
Revenue Next 5Y6.18%

3.3 Evolution

  • The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
DORM Yearly Revenue VS EstimatesDORM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 500M 1B 1.5B 2B 2.5B
DORM Yearly EPS VS EstimatesDORM Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2 4 6 8 10

5

4. Valuation

4.1 Price/Earnings Ratio

  • DORM is valuated correctly with a Price/Earnings ratio of 14.47.
  • Based on the Price/Earnings ratio, DORM is valued a bit cheaper than 71.43% of the companies in the same industry.
  • DORM's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.54.
  • With a Price/Forward Earnings ratio of 13.37, DORM is valued correctly.
  • DORM's Price/Forward Earnings is on the same level as the industry average.
  • When comparing the Price/Forward Earnings ratio of DORM to the average of the S&P500 Index (24.31), we can say DORM is valued slightly cheaper.
Industry RankSector Rank
PE 14.47
Fwd PE 13.37
DORM Price Earnings VS Forward Price EarningsDORM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of DORM is on the same level as its industry peers.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of DORM is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 37.42
EV/EBITDA 10.55
DORM Per share dataDORM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • DORM has an outstanding profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as DORM's earnings are expected to grow with 14.91% in the coming years.
PEG (NY)0.55
PEG (5Y)0.66
EPS Next 2Y16.16%
EPS Next 3Y14.91%

0

5. Dividend

5.1 Amount

  • DORM does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

DORMAN PRODUCTS INC

NASDAQ:DORM (1/15/2026, 8:00:01 PM)

After market: 128.79 0 (0%)

128.79

+2.69 (+2.13%)

Chartmill FA Rating
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobile Components
Earnings (Last)10-27
Earnings (Next)02-24
Inst Owners87.15%
Inst Owner Change-0.01%
Ins Owners13.6%
Ins Owner Change-1.38%
Market Cap3.94B
Revenue(TTM)2.13B
Net Income(TTM)247.63M
Analysts82.86
Price Target176.97 (37.41%)
Short Float %4.32%
Short Ratio5
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.25%
Min EPS beat(2)2.92%
Max EPS beat(2)11.58%
EPS beat(4)4
Avg EPS beat(4)15.07%
Min EPS beat(4)2.92%
Max EPS beat(4)36.11%
EPS beat(8)8
Avg EPS beat(8)23.63%
EPS beat(12)8
Avg EPS beat(12)10.09%
EPS beat(16)9
Avg EPS beat(16)7.08%
Revenue beat(2)1
Avg Revenue beat(2)-0.17%
Min Revenue beat(2)-3.26%
Max Revenue beat(2)2.92%
Revenue beat(4)2
Avg Revenue beat(4)0.68%
Min Revenue beat(4)-3.26%
Max Revenue beat(4)3.34%
Revenue beat(8)2
Avg Revenue beat(8)-0.93%
Revenue beat(12)3
Avg Revenue beat(12)-0.87%
Revenue beat(16)6
Avg Revenue beat(16)0.21%
PT rev (1m)0%
PT rev (3m)4.7%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.21%
EPS NY rev (1m)0%
EPS NY rev (3m)0.86%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.1%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.27%
Valuation
Industry RankSector Rank
PE 14.47
Fwd PE 13.37
P/S 1.85
P/FCF 37.42
P/OCF 27.53
P/B 2.65
P/tB 5.07
EV/EBITDA 10.55
EPS(TTM)8.9
EY6.91%
EPS(NY)9.63
Fwd EY7.48%
FCF(TTM)3.44
FCFY2.67%
OCF(TTM)4.68
OCFY3.63%
SpS69.57
BVpS48.51
TBVpS25.41
PEG (NY)0.55
PEG (5Y)0.66
Graham Number98.56
Profitability
Industry RankSector Rank
ROA 9.7%
ROE 16.7%
ROCE 17.45%
ROIC 13.16%
ROICexc 13.53%
ROICexgc 21.03%
OM 16.71%
PM (TTM) 11.65%
GM 41.88%
FCFM 4.95%
ROA(3y)6.22%
ROA(5y)7.06%
ROE(3y)12.47%
ROE(5y)12.81%
ROIC(3y)9.34%
ROIC(5y)9.92%
ROICexc(3y)9.58%
ROICexc(5y)10.64%
ROICexgc(3y)16.14%
ROICexgc(5y)16.08%
ROCE(3y)13.07%
ROCE(5y)14.22%
ROICexgc growth 3Y8.15%
ROICexgc growth 5Y10.63%
ROICexc growth 3Y3.74%
ROICexc growth 5Y2.76%
OM growth 3Y4.55%
OM growth 5Y6.44%
PM growth 3Y-1.1%
PM growth 5Y2.27%
GM growth 3Y5.26%
GM growth 5Y3.2%
F-Score7
Asset Turnover0.83
Health
Industry RankSector Rank
Debt/Equity 0.28
Debt/FCF 4.33
Debt/EBITDA 1.02
Cap/Depr 67.78%
Cap/Sales 1.78%
Interest Coverage 11.7
Cash Conversion 34.78%
Profit Quality 42.47%
Current Ratio 2.94
Quick Ratio 1.19
Altman-Z 4.71
F-Score7
WACC8.95%
ROIC/WACC1.47
Cap/Depr(3y)78.22%
Cap/Depr(5y)67.78%
Cap/Sales(3y)2.14%
Cap/Sales(5y)1.86%
Profit Quality(3y)77.16%
Profit Quality(5y)84.08%
High Growth Momentum
Growth
EPS 1Y (TTM)36.71%
EPS 3Y15.37%
EPS 5Y21.83%
EPS Q2Q%33.67%
EPS Next Y26.18%
EPS Next 2Y16.16%
EPS Next 3Y14.91%
EPS Next 5Y7.8%
Revenue 1Y (TTM)7.94%
Revenue growth 3Y14.31%
Revenue growth 5Y15.18%
Sales Q2Q%7.93%
Revenue Next Year8.33%
Revenue Next 2Y6.78%
Revenue Next 3Y6.27%
Revenue Next 5Y6.18%
EBIT growth 1Y25.27%
EBIT growth 3Y19.51%
EBIT growth 5Y22.59%
EBIT Next Year38.49%
EBIT Next 3Y15.9%
EBIT Next 5YN/A
FCF growth 1Y-8.15%
FCF growth 3Y33.52%
FCF growth 5Y23.87%
OCF growth 1Y-11.46%
OCF growth 3Y32.07%
OCF growth 5Y19.38%

DORMAN PRODUCTS INC / DORM FAQ

What is the ChartMill fundamental rating of DORMAN PRODUCTS INC (DORM) stock?

ChartMill assigns a fundamental rating of 6 / 10 to DORM.


Can you provide the valuation status for DORMAN PRODUCTS INC?

ChartMill assigns a valuation rating of 5 / 10 to DORMAN PRODUCTS INC (DORM). This can be considered as Fairly Valued.


What is the profitability of DORM stock?

DORMAN PRODUCTS INC (DORM) has a profitability rating of 9 / 10.


Can you provide the financial health for DORM stock?

The financial health rating of DORMAN PRODUCTS INC (DORM) is 7 / 10.


How sustainable is the dividend of DORMAN PRODUCTS INC (DORM) stock?

The dividend rating of DORMAN PRODUCTS INC (DORM) is 0 / 10 and the dividend payout ratio is 0%.